arrow
K

Keith D. Lindor

Mayo Clinic
H指数:117
被引数:5.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

原发性胆汁性胆管炎药物评估和监管批准: 我们从这里走向何方?

2024-03-226
OAAI
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival
2023-05-0810
OAAI
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis

熊去氧胆酸治疗引起的GLOBE评分变化与原发性胆汁性胆管炎患者无肝移植生存率相关

2022-12-147
OAAI
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
2022-12-0143
OA
Liver-transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
2022-09-2213
OAAI
Machine learning in primary biliary cholangitis: A novel approach for risk stratification
2022-01-0714
PRE
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
2021-08-0130
OAAI
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis

亚太肝脏研究协会临床实践指南:自身免疫性肝炎的诊断与管理

2021-05-0450
OAAI
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis
2021-05-0415
PRE
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis
2021-03-010
PREAI